Figure 1.
Figure 1. Characterization of ADCT-402. (A) Structure of ADCT-402. (B) ADCT-402 characterized by size exclusion chromatography. (C) Reduced reverse phase liquid chromatography depicting reduced heavy and light chains of ADCT-402. (D) Hydrophobic interaction chromatography depicting drug–antibody ratio forms of ADCT-402.

Characterization of ADCT-402. (A) Structure of ADCT-402. (B) ADCT-402 characterized by size exclusion chromatography. (C) Reduced reverse phase liquid chromatography depicting reduced heavy and light chains of ADCT-402. (D) Hydrophobic interaction chromatography depicting drug–antibody ratio forms of ADCT-402.

Close Modal

or Create an Account

Close Modal
Close Modal